keyword
MENU ▼
Read by QxMD icon Read
search

enoxaparin for DVT prophylaxis

keyword
https://www.readbyqxmd.com/read/27900627/extended-duration-versus-short-duration-pharmacological-thromboprophylaxis-in-acutely-ill-hospitalized-medical-patients-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#1
Aaron Y L Liew, Siavash Piran, John W Eikelboom, James D Douketis
Extended-duration pharmacological thromboprophylaxis, for at least 28 days, is effective for the prevention of symptomatic venous thromboembolism (VTE) in high-risk surgical patients but is of uncertain benefit in hospitalized medical patients. We aimed to evaluate the efficacy and safety of extended-duration thromboprophylaxis in hospitalized medical patients. We conducted a systematic PubMed, Medline and EMBASE literature search until June 2016 and a meta-analysis of randomized controlled trials which compared extended-duration with short-duration thromboprophylaxis in hospitalized medical patients...
November 30, 2016: Journal of Thrombosis and Thrombolysis
https://www.readbyqxmd.com/read/27777435/a-phase-ii-clinical-trial-of-the-efficacy-and-safety-of-short-term-3-days-enoxaparin-for-the-prevention-of-venous-thromboembolism-after-gastric-cancer-surgery
#2
Shinji Kuroda, Satoru Kikuchi, Masahiko Nishizaki, Shunsuke Kagawa, Shiro Hinotsu, Toshiyoshi Fujiwara
Although intermittent pneumatic compression (IPC) has become common as perioperative prophylaxis for venous thromboembolism (VTE) consisting of pulmonary thromboembolism (PE) and deep vein thrombosis (DVT), the prophylactic effect against VTE, especially lethal PE, is not yet satisfactory. Therefore, pharmacologic prophylaxis, such as with enoxaparin, is desirable. While the efficacy and safety of enoxaparin have been proven in several clinical trials, concern about bleeding with longterm (at least 7 days) use have potentially decreased its widespread adoption...
October 2016: Acta Medica Okayama
https://www.readbyqxmd.com/read/27664226/enoxaparin-induced-hepatotoxicity-an-under-recognised-complication-of-enoxaparin-therapy
#3
Katie Ann Pivarnik, Fred Schiffman, James Sullivan, Arkadiy Finn
Low-molecular-weight heparins including enoxaparin are commonly used for anticoagulation as prophylaxis and treatment for deep vein thrombosis (DVT). Prescribers of enoxaparin monitor for common side effects, such as bleeding and thrombocytopenia, but hepatotoxicity, a less common and under-reported adverse effect, may be overlooked. This report describes a case of enoxaparin-induced hepatotoxicity in a 57-year-old man who was started on the drug for a DVT. Within 3 days of taking enoxaparin, elevated transaminases were noted, and the drug was discontinued after 6 days...
2016: BMJ Case Reports
https://www.readbyqxmd.com/read/27633687/an-analysis-of-deep-vein-thrombosis-in-burn-patients-part-ii-a-randomized-and-controlled-study-of-thrombo-prophylaxis-with-low-molecular-weight-heparin
#4
Rajeev B Ahuja, Priya Bansal, Gaurav S Pradhan, Manju Subberwal
INTRODUCTION: Morbidity and mortality from venous thrombo-embolism (VTE) remains a significant problem for trauma and medical patients and there are established guidelines for prophylaxis in these patients. However, the efficacy and safety of VTE prophylaxis in thermally injured patients continue to be elusive as it has never been studied in a prospective, randomized fashion. Selective use of VTE prophylaxis, for high risk patients, is practiced by some burn units even if objective evidence is lacking for majority of risk factors enunciated in burn patients...
September 12, 2016: Burns: Journal of the International Society for Burn Injuries
https://www.readbyqxmd.com/read/27580310/efficacy-and-safety-of-rivaroxaban-thromboprophylaxis-after-arthroplasty-of-the-hip-or-knee-retrospective-cohort-study
#5
L Loganathan, A Hua, S Patel, C Gibbons, M P Vizcaychipi
Introduction Venous thromboembolism (VTE) is a potentially fatal complication of hip arthroplasty and knee arthroplasty. The National Institute for Health and Care Excellence recommend rivaroxaban for VTE prevention. Amid concerns over bleeding complications, the modified thromboprophylaxis policy of Chelsea and Westminster Hospital (CWH; London, UK) advises enoxaparin given after surgery in the inpatient setting followed by rivaroxaban upon hospital discharge. This retrospective study investigated the efficacy and safety of rivaroxaban in this novel, modified venous-prophylaxis regimen in a surgical orthopaedic cohort at CWH...
September 2016: Annals of the Royal College of Surgeons of England
https://www.readbyqxmd.com/read/27488490/anti-xa-guided-enoxaparin-thromboprophylaxis-reduces-rate-of-deep-venous-thromboembolism-in-high-risk-trauma-patients
#6
George A Singer, Gina Riggi, Charles A Karcutskie, Tanaz M Vaghaiwalla, Howard M Lieberman, Enrique Ginzburg, Nicholas Namias, Edward B Lineen
BACKGROUND: Appropriate prophylaxis against venous thromboembolism (VTE) remains undefined. This study evaluated an anti-Xa-guided enoxaparin thromboprophylaxis protocol on the incidence of VTE in high-risk trauma patients based upon Greenfield's Risk Assessment Profile (RAP) score. METHODS: This is a retrospective observational study of patients admitted to a trauma ICU over a 12-month period. Patients were included if they received anti-Xa-guided enoxaparin thromboprophylaxis...
August 3, 2016: Journal of Trauma and Acute Care Surgery
https://www.readbyqxmd.com/read/27284271/clinical-benefit-of-graduated-compression-stockings-for-prevention-of-venous-thromboembolism-after-total-knee-arthroplasty-post-hoc-analysis-of-a-phase-3-clinical-study-of-edoxaban
#7
Takeshi Fuji, Satoru Fujita, Tetsuya Kimura, Kei Ibusuki, Kenji Abe, Shintaro Tachibana, Mashio Nakamura
BACKGROUND: Guidelines from the Japanese Circulation Society recommend prophylaxis with anticoagulation plus intermittent pneumatic compression or graduated compression stockings (GCS) among patients at the highest risk for developing venous thromboembolism (VTE). However, the benefits of concomitant GCS use for patients undergoing total knee arthroplasty (TKA) and receiving anticoagulation remain unknown. In this study, the efficacy of GCS plus anticoagulation compared with anticoagulation alone was evaluated among patients undergoing TKA...
2016: Thrombosis Journal
https://www.readbyqxmd.com/read/27246450/apixaban-versus-enoxaparin-in-the-prevention-of-venous-thromboembolism-following-total-knee-arthroplasty-a-single-centre-single-surgeon-retrospective-analysis
#8
D A L King, R E Pow, D M Dickison, P R Vale
BACKGROUND: There is a high risk of developing venous thromboembolism (VTE) following total knee arthroplasty (TKA). Conventional thromboprophylactic agents have limitations, such as route of administration, the need for monitoring, narrow therapeutic windows and interactions. Apixaban is a new oral anticoagulant with the potential to overcome these limitations. AIMS: To report the efficacy and safety of apixaban and low-molecular-weight heparin, enoxaparin, in VTE prophylaxis following TKA...
September 2016: Internal Medicine Journal
https://www.readbyqxmd.com/read/26927278/risk-of-ventriculostomy-associated-hemorrhage-in-patients-with-aneurysmal-subarachnoid-hemorrhage-treated-with-anticoagulant-thromboprophylaxis
#9
Joseph Zachariah, Kendall A Snyder, Christopher S Graffeo, Deependra R Khanal, Giuseppe Lanzino, Eelco F M Wijdicks, Alejandro A Rabinstein
BACKGROUND: Patients with subarachnoid hemorrhage (SAH) frequently need a ventriculostomy for treatment of hydrocephalus. In some ICU practices, a ventriculostomy is considered a relative contraindication for subcutaneous heparin. We studied the risk of ventriculostomy-associated hemorrhage and deep venous thrombosis (DVT) in patients with anticoagulant prophylaxis. METHODS: This is a retrospective study of 241 consecutive patients with SAH and ventriculostomies treated at Mayo Clinic, Rochester from 2001 to 2014...
October 2016: Neurocritical Care
https://www.readbyqxmd.com/read/26373044/polymeric-nanoparticles-of-enoxaparin-as-a-delivery-system-in-vivo-evaluation-in-normal-rats-and-in-a-venous-thrombosis-rat-model
#10
Carla Pazzini, Priscyla D Marcato, Lucas Bessa Prado, Aline Morandi Alessio, Nelci Fenalt Höehr, Silmara Montalvão, Devanira Paixão, Nelson Durán, Joyce Maria Annichino-Bizzacchi
Enoxaparin is an anticoagulant widely used in the treatment and prophylaxis of deep vein thrombosis (DVT). The subcutaneous route of administration, sometimes in repeated doses during 24 hours, represents a limitation to its use. Thus, the development of a product that can be administered either subcutaneously, in a smaller number of applications becomes a major challenge, with interesting clinical applications. The use of a system for sustained release of drugs can help to meet that goal, by protecting and enabling a gradual released of the agent...
July 2015: Journal of Nanoscience and Nanotechnology
https://www.readbyqxmd.com/read/26333856/thromboprophylaxis-with-apixaban-and-the-risk-of-pulmonary-embolism-in-patients-undergoing-knee-replacement-surgery
#11
Madan Raj Aryal, Anil Pandit, Sushil Ghimire, Ranjan Pathak, Paras Karmacharya, Dilli Ram Poudel, Fadi E Shamoun
BACKGROUND: Apixaban, a novel oral anticoagulant, is also used for deep vein thrombosis (DVT) prophylaxis. In this study, we sought to critically evaluate the differences in the rates of symptomatic DVT and bleeding, and analyze the rates of pulmonary embolism (PE) in subgroups of patients from ADVANCE I and II trials given their similar indication and design. METHODS: Studies were identified through electronic literature searches of MEDLINE, clinicaltrial.gov, SCOPUS, and EMBASE up to January 2014...
2015: Journal of Community Hospital Internal Medicine Perspectives
https://www.readbyqxmd.com/read/26317819/heparin-versus-enoxaparin-for-prevention-of-venous-thromboembolism-after-trauma-a-randomized-noninferiority-trial
#12
RANDOMIZED CONTROLLED TRIAL
Erik J Olson, Jesse Bandle, Richard Y Calvo, Steven R Shackford, Casey E Dunne, Jan-Michael Van Gent, Ashley L Zander, Harminder Sikand, Michael S Bongiovanni, Michael J Sise, C Beth Sise
BACKGROUND: Research comparing enoxaparin with unfractionated heparin (UFH) given every 12 hours for venous thromboembolism (VTE) prophylaxis after trauma overlooks original recommendations that UFH be given every 8 hours. We conducted a prospective, randomized, noninferiority trial comparing UFH every 8 hours and standard enoxaparin every 12 hours. We hypothesized that the incidence of VTE in trauma patients receiving UFH every 8 hours would be no more than 10% higher than that in patients receiving enoxaparin every 12 hours...
December 2015: Journal of Trauma and Acute Care Surgery
https://www.readbyqxmd.com/read/26200403/comparison-of-switch-therapy-modalities-enoxaparin-to-rivaroxaban-dabigatran-and-enoxaparin-monotherapy-after-hip-and-knee-replacement
#13
RANDOMIZED CONTROLLED TRIAL
Turhan Özler, Çağatay Uluçay, Ayberk Önal, Faik Altıntaş
OBJECTIVE: Prevention of deep venous thrombosis (DVT) and associated pulmonary embolism following major orthopedic surgeries is challenging, and there is an increased interest in developing new treatment strategies. We compared 2 switch-therapy modalities-enoxaparin to rivaroxaban and enoxaparin to dabigatran-and enoxaparin monotherapy for preventing DVT after total knee arthroplasty (TKA) and total hip arthroplasty (THA). METHODS: This was a prospective, non-blinded, randomized controlled study...
2015: Acta Orthopaedica et Traumatologica Turcica
https://www.readbyqxmd.com/read/25998183/deep-vein-thrombosis-screening-and-risk-factors-in-a-high-risk-trauma-population
#14
Christopher P Michetti, Elizabeth Franco, Jonathan Coleman, Anna Bradford, Amber W Trickey
BACKGROUND: Trauma patients requiring acute inpatient rehabilitation are significantly injured, with increased risk for deep vein thrombosis (DVT). We evaluated routine screening for occult DVT in such patients, and analyzed DVT risk factors. MATERIALS AND METHODS: Data from level I trauma center patients discharged to a single acute rehabilitation center (ARC) from 2007-2011 were retrospectively reviewed. Routine lower extremity duplex was performed on ARC admission...
December 2015: Journal of Surgical Research
https://www.readbyqxmd.com/read/25982217/chemical-prophylaxis-to-prevent-venous-thromboembolism-in-morbid-obesity-literature-review-and-dosing-recommendations
#15
REVIEW
Jeremy W Vandiver, Leticia I Ritz, Jeffrey T Lalama
Pharmacologic prophylaxis of deep vein thrombosis and venous thromboembolism (VTE) is an important aspect of medical care, particularly in the inpatient setting. Low-molecular weight heparins, heparin, and fondaparinux are commonly used agents to prevent VTE, each of which has well established dosing regimens in patients with normal body mass index. Dosing of these medications in morbidly obese populations (BMI > 40 kg/m(2)) is not as clearly defined in guidelines. This article reviews published data to support specific dosing regimens and monitoring strategies of these agents in this population...
April 2016: Journal of Thrombosis and Thrombolysis
https://www.readbyqxmd.com/read/25972699/thromboembolic-disease-after-knee-arthroplasty-is-rare-in-southern-iran
#16
G Hossain Shahcheraghi, Mahzad Javid, Mohammad M Arasteh
BACKGROUND: Thromboembolic disease (TED) after knee arthroplasty occurs infrequently in Iran. The aim of this study was to examine the incidence of TED in patients with osteoarthritis undergoing knee replacement in Southern Iran while on prophylaxis. MATERIALS & METHODS: In a case series study from January to December 2012, 100 consecutive total knee arthroplasty (TKA) candidates were evaluated for TED by clinical evaluation and Doppler sonography preoperatively and 2 months postoperatively and by clinical evaluation one year after surgery...
June 2015: Journal of Orthopaedics
https://www.readbyqxmd.com/read/25909208/generic-versus-branded-enoxaparin-in-prophylaxis-and-treatment-of-vein-thrombosis
#17
RANDOMIZED CONTROLLED TRIAL
Ivan Benaduce Casella, Pedro Puech-Leão
OBJECTIVES: to compare the biological efficacy of generic enoxaparin (HeptronTM) versus branded Sanofi-Aventis enoxaparin for prophylaxis and treatment of lower-extremity deep venous thrombosis (DVT) in a prospective, randomized, open-label study. METHODS: patients with diagnosed lower-extremity DVT (therapeutic branch, n=57) and patients requiring venous thromboembolism (VTE) prophylaxis after arterial vascular surgery or major lower-extremity amputations (prophylactic branch, n=57) were randomized to receive generic or branded enoxaparin for up to seven days...
January 2015: Revista da Associação Médica Brasileira
https://www.readbyqxmd.com/read/25620436/the-effort-trial-preoperative-enoxaparin-versus-postoperative-fondaparinux-for-thromboprophylaxis-in-bariatric-surgical-patients-a-randomized-double-blind-pilot-trial
#18
RANDOMIZED CONTROLLED TRIAL
Kimberley E Steele, Joseph Canner, Gregory Prokopowicz, Franco Verde, Aleksandra Beselman, Ransom Wyse, Junnan Chen, Michael Streiff, Thomas Magnuson, Anne Lidor, Michael Schweitzer
BACKGROUND: Prophylaxis for venous thromboembolism is routinely performed for all patients undergoing bariatric surgery. However, there is disagreement regarding the optimal dosing and duration of anticoagulant therapy. Furthermore, there is little data regarding the incidence of asymptomatic deep venous thrombosis (DVT) in this population. Our objective was to conduct a pilot randomized double blind study to evaluate the pharmacodynamic parameters of 2 different anticoagulation medications (enoxaparin and fondaparinux) administered to patients undergoing bariatric surgery...
May 2015: Surgery for Obesity and related Diseases: Official Journal of the American Society for Bariatric Surgery
https://www.readbyqxmd.com/read/25433153/thrombosis-prevention-in-lower-extremity-arthroplasty-mobile-compression-device-or-pharmacological-therapy
#19
Clifford W Colwell
Venous thromboembolic (VTE) events, either deep vein thromboses (DVT) or pulmonary emboli (PE), are important complications in patients undergoing knee or hip arthroplasty. Symptomatic VTE rates observed in total joint arthroplasty patients using the mobile compression device with home use capability were non-inferior to rates reported for pharmacological prophylaxis, including warfarin, enoxaparin, rivaroxaban, and dabigatran. Major bleeding in total hip arthroplasty was less using the mobile compression device than using low molecular weight heparin...
November 2014: Surgical Technology International
https://www.readbyqxmd.com/read/25309725/venous-thromboembolism-prophylaxis-in-patients-with-traumatic-brain-injury-a-systematic-review
#20
Yohalakshmi Chelladurai, Kent A Stevens, Elliott R Haut, Daniel J Brotman, Ritu Sharma, Kenneth M Shermock, Sosena Kebede, Sonal Singh, Jodi B Segal
OBJECTIVE: There is considerable practice variation and clinical uncertainty about the choice of prophylaxis for preventing venous thromboembolism in patients with traumatic brain injury. We performed a systematic review to assess both the effectiveness and safety of pharmacologic and mechanical prophylaxis, and the optimal time to initiate pharmacologic prophylaxis in hospitalized patients with traumatic brain injury. DATA SOURCES AND STUDY SELECTION: MEDLINE®, EMBASE®, SCOPUS, CINAHL, International Pharmaceutical Abstracts, clinicaltrial...
2013: F1000Research
keyword
keyword
51911
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"